Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Improvement in Inner Retinal Function in Glaucoma with Nicotinamide (Vitamin B3) Supplementation: A Crossover Randomised Clinical Trial

View ORCID ProfileFlora Hui, Jessica Tang, Pete A Williams, Myra B McGuinness, Xavier Hadoux, Robert J Casson, Michael Coote, Ian A Trounce, Keith R. Martin, Peter van Wijngaarden, Jonathan G Crowston
doi: https://doi.org/10.1101/2020.01.28.20019075
Flora Hui
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Flora Hui
  • For correspondence: f.hui@unimelb.edu.au
Jessica Tang
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
2Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pete A Williams
3Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myra B McGuinness
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Hadoux
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert J Casson
4Ophthalmic Research Laboratories, Discipline of Ophthalmology and Visual Sciences, University of Adelaide, Adelaide, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Coote
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
2Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian A Trounce
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
2Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith R. Martin
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
2Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Australia
5Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter van Wijngaarden
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
2Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan G Crowston
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
2Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Australia
6Centre for Vision Research, Duke-NUS Medical School, Singapore
7Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Retinal ganglion cells endure significant metabolic stress in glaucoma but maintain capacity to recover function. Nicotinamide, a precursor of NAD+, is low in serum of glaucoma patients and its supplementation provides robust protection of retinal ganglion cells in preclinical models. However, the potential of nicotinamide in human glaucoma is unknown.

Background To determine whether nicotinamide supplementation alongside conventional IOP-lowering therapy improves retinal ganglion cell function in glaucoma.

Design Crossover, double-masked, randomised clinical trial. Participants recruited from two tertiary care centres.

Participants Fifty-seven participants, diagnosed and treated for primary glaucoma, enrolled.

Methods Participants received oral placebo or nicotinamide and reviewed six-weekly. Participants commenced 6-weeks of 1.5 grams/day then 6 weeks of 3.0 grams/day followed by crossover without washout. Visual function measured using electroretinography and perimetry.

Main outcome measures Change in inner retinal function, determined by photopic negative response (PhNR) parameters: saturated PhNR amplitude (Vmax), ratio of PhNR/b-wave amplitude (Vmax ratio).

Results PhNR Vmax improved beyond 95% coefficient of repeatability (COR) in 23% of participants following nicotinamide versus 9% on placebo. Overall, Vmax improved by 14.8% [95% CI: 2.8%, 26.9%], (p=0.02) on nicotinamide and 5.2% [−4.2%, 14.6%], (p=0.27) on placebo. Vmax ratio improved by 12.6% [5.0%, 20.2%], (p=0.002) following nicotinamide, 3.6% [−3.4%, 10.5%], (p=0.30) on placebo. A trend for improved visual field mean deviation was observed with 27% improving ≥1dB on nicotinamide and fewer deteriorating (4%) compared to placebo (p=0.02).

Conclusions Nicotinamide supplementation can improve inner retinal function in glaucoma. Further studies underway to elucidate the effects of long-term nicotinamide supplementation.

Trial Registration ANZCTR trial ID: ACTRN12617000809336 https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373001

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ACTRN12617000809336

Clinical Protocols

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373001

Funding Statement

Ophthalmic Research Institute of Australia (FH); Jack Brockhoff Foundation, Marian and E.H. Flack Trust – JBF Grant number 4354 – 2017 (FH); Jean Miller Foundation (JGC); Connie and Craig Kimberley Fund (IAT, JGC). Board of Research Faculty Funded Career position (Karolinska Institutet) (PAW). The Centre for Eye Research Australia receives operational infrastructure support from the Victorian Government. The funding organisations had no role in the design or conduct of this research.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Financial support: Ophthalmic Research Institute of Australia (FH); Jack Brockhoff Foundation, Marian and E.H. Flack Trust – JBF Grant number 4354 – 2017 (FH); Jean Miller Foundation (JGC); Connie and Craig Kimberley Fund (IAT, JGC). Board of Research Faculty Funded Career position (Karolinska Institutet) (PAW). The Centre for Eye Research Australia receives operational infrastructure support from the Victorian Government. The funding organisations had no role in the design or conduct of this research.

  • Abbreviations and Acronyms: ATP - adenosine triphosphate, CI – confidence interval, COR – coefficient of repeatability, ERG – electroretinogram, IOL – intraocular lens, IOP – intraocular pressure, IQR – interquartile range, MD – mean deviation, MLS – mean light sensitivity, NAD+ – nicotinamide adenine dinucleotide, NAM – nicotinamide, PL – placebo, POAG – primary open-angle glaucoma, PhNR – photopic negative response, PSD – pattern standard deviation, Q1 – lower quartile, Q3 – upper quartile, RGC – retinal ganglion cell, RNFL – retinal nerve fibre layer, VF – visual field, Vmax – saturating amplitude

  • Conflict of interest: No conflicting relationship exists for any author.

  • Data sharing statement: Clinical data was collected at the Centre for Eye Research Australia in collaboration with the Royal Victorian Eye and Ear Hospital and Melbourne Eye Specialists. These data are not publicly available. Source data of graphs may be available as source files if requested. A description of the code used to analyse the electroretinogram data is described in the Methods section, and we have also published this previously (Tang et al, 2018).

Data Availability

Clinical data was collected at the Centre for Eye Research Australia in collaboration with the Royal Victorian Eye and Ear Hospital and Melbourne Eye Specialists. These data are not publicly available. Source data of graphs may be available as source files if requested. A description of the code used to analyze the electroretinogram data is described in the Methods section, and we have also published this previously (Tang et al, 2018).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 12, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Improvement in Inner Retinal Function in Glaucoma with Nicotinamide (Vitamin B3) Supplementation: A Crossover Randomised Clinical Trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Improvement in Inner Retinal Function in Glaucoma with Nicotinamide (Vitamin B3) Supplementation: A Crossover Randomised Clinical Trial
Flora Hui, Jessica Tang, Pete A Williams, Myra B McGuinness, Xavier Hadoux, Robert J Casson, Michael Coote, Ian A Trounce, Keith R. Martin, Peter van Wijngaarden, Jonathan G Crowston
medRxiv 2020.01.28.20019075; doi: https://doi.org/10.1101/2020.01.28.20019075
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Improvement in Inner Retinal Function in Glaucoma with Nicotinamide (Vitamin B3) Supplementation: A Crossover Randomised Clinical Trial
Flora Hui, Jessica Tang, Pete A Williams, Myra B McGuinness, Xavier Hadoux, Robert J Casson, Michael Coote, Ian A Trounce, Keith R. Martin, Peter van Wijngaarden, Jonathan G Crowston
medRxiv 2020.01.28.20019075; doi: https://doi.org/10.1101/2020.01.28.20019075

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Ophthalmology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (859)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (249)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8562)
  • Forensic Medicine (4)
  • Gastroenterology (384)
  • Genetic and Genomic Medicine (1751)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1243)
  • Health Policy (621)
  • Health Systems and Quality Improvement (468)
  • Hematology (196)
  • HIV/AIDS (374)
  • Infectious Diseases (except HIV/AIDS) (10302)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (212)
  • Neurology (1678)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (451)
  • Oncology (929)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (253)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1769)
  • Public and Global Health (3840)
  • Radiology and Imaging (624)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)